样式: 排序: IF: - GO 导出 标记为已读
-
Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden Int. J. Cancer (IF 6.4) Pub Date : 2024-03-25 Ulf Strömberg, Anders Berglund, Stefan Carlsson, Camilla Thellenberg Karlsson, Mats Lambe, Ingela Franck Lissbrant, Pär Stattin, Ola Bratt
-
How have US colorectal cancer mortality trends changed in the past 20 years? Int. J. Cancer (IF 6.4) Pub Date : 2024-03-25 Jia Yi Tan, Yong‐Hao Yeo, Wern Lynn Ng, Zhi Ven Fong, Justin T. Brady
-
Three‐year survival of breast cancer patients attending a one‐stop breast care clinic nested within a primary care health facility in sub‐Saharan Africa‐Zambia Int. J. Cancer (IF 6.4) Pub Date : 2024-03-25 Mutumba Songiso, Olivier Nuñez, Anna Cabanes, Mpimpa Mutale, Jabulani Munalula, George Pupwe, Ronda Henry‐Tillman, Groesbeck P. Parham
-
Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy Int. J. Cancer (IF 6.4) Pub Date : 2024-03-23 Luigino Dal Maso, Federica Toffolutti, Angela De Paoli, Fabiola Giudici, Silvia Francisci, Lauro Bucchi, Manuel Zorzi, Mario Fusco, Adele Caldarella, Silvia Rossi, Roberta De Angelis, Laura Botta, Alessandra Ravaioli, Claudia Casella, Antonino Musolino, Maria Francesca Vitale, Lucia Mangone, Anna Clara Fanetti, Eva Carpin, Maria Giovanna Burgio Lo Monaco, Enrica Migliore, Maria Letizia Gambino, Margherita
-
Correction to “Triptolide reverses hypoxia‐induced epithelial‐mesenchymal transition and stem‐like features in pancreatic cancer by NF‐κB downregulation” Int. J. Cancer (IF 6.4) Pub Date : 2024-03-23
Liu L, Salnikov AV, Bauer N, et al. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Int J Cancer. 2014;134(10):2489-2503. doi:10.1002/ijc.28583. Concerns have been raised by a third party about the appearance of Figure 5E, suggesting that the Jagged 1 bands have been cropped and pasted, giving the impression
-
Metformin and other anti‐diabetic medication use and breast cancer incidence in the Nurses' Health Studies Int. J. Cancer (IF 6.4) Pub Date : 2024-03-23 Tengteng Wang, Boyang Chai, Wendy Y. Chen, Michelle D. Holmes, Jennifer Erdrich, Frank B. Hu, Bernard A. Rosner, Rulla M. Tamimi, Walter C. Willett, Jae H. Kang, A. Heather Eliassen
-
Novel serum protein biomarker panel for early diagnosis of pancreatic cancer Int. J. Cancer (IF 6.4) Pub Date : 2024-03-23 Sooin Byeon, Matthew J. McKay, Mark P. Molloy, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni
-
Biopsy‐verified vulvar lichen sclerosus: Incidence trends 1997–2022 and increased risk of vulvar squamous precancer and squamous cell carcinoma Int. J. Cancer (IF 6.4) Pub Date : 2024-03-22 Louise Baandrup, Charlotte G. Hannibal, Rasmus Hertzum‐Larsen, Susanne K. Kjær
-
Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort Int. J. Cancer (IF 6.4) Pub Date : 2024-03-20 Clare Gilham, Belinda Nedjai, Dorota Scibior‐Bentkowska, Caroline Reuter, Rawinder Banwait, Adam R. Brentnall, Jack Cuzick, Julian Peto, Attila T. Lorincz
-
Shaping the immune‐suppressive microenvironment on tumor‐associated myeloid cells through tumor‐derived exosomes Int. J. Cancer (IF 6.4) Pub Date : 2024-03-19 Hongmei Wang, Shanshan Liu, Jianhao Zhan, Yuqing Liang, Xiaoping Zeng
-
Darolutamide does not interfere with OATP‐mediated uptake of docetaxel Int. J. Cancer (IF 6.4) Pub Date : 2024-03-16 Stefan A. J. Buck, Zahra Talebi, Thomas Drabison, Yan Jin, Alice A. Gibson, Peng Hu, Peter de Bruijn, Corrina M. A. de Ridder, Debra Stuurman, Shuiying Hu, Wytske M. van Weerden, Stijn L. W. Koolen, Ronald de Wit, Alex Sparreboom, Ron H. J. Mathijssen, Eric D. Eisenmann
-
Multi‐omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma Int. J. Cancer (IF 6.4) Pub Date : 2024-03-16 Anastasia Brativnyk, Jørgen Ankill, Åslaug Helland, Thomas Fleischer
-
Systemic versus localized Bacillus Calmette Guérin immunotherapy of bladder cancer promotes an anti‐tumoral microenvironment: Novel role of trained immunity Int. J. Cancer (IF 6.4) Pub Date : 2024-03-14 Aline Atallah, Arielle Grossman, Richard W. Nauman, Jean‐François Paré, Adam Khan, D. Robert Siemens, Tiziana Cotechini, Charles H. Graham
-
Association of female reproductive and hormonal factors with gallbladder cancer risk in Asia: A pooled analysis of the Asia Cohort Consortium Int. J. Cancer (IF 6.4) Pub Date : 2024-03-13 Aesun Shin, Sooyoung Cho, Sarah Krull Abe, Md Rashedul Islam, Md Shafiur Rahman, Eiko Saito, Sayada Zartasha Kazmi, Ryoko Katagiri, Melissa Merritt, Ji‐Yeob Choi, Xiao‐Ou Shu, Norie Sawada, Akiko Tamakoshi, Woon‐Puay Koh, Ritsu Sakata, Atsushi Hozawa, Jeongseon Kim, Sue K. Park, Sun‐Seog Kweon, Wanqing Wen, Shoichiro Tsugane, Takashi Kimura, Jian‐Min Yuan, Seiki Kanemura, Yumi Sugawara, Min‐Ho Shin
-
-
Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004–2015: A comparative population‐based study Int. J. Cancer (IF 6.4) Pub Date : 2024-03-13 Hanne Peirelinck, Maya Schulpen, Raoull Hoogendijk, An Van Damme, Rob Pieters, Kris Henau, Nancy Van Damme, Henrike E. Karim‐Kos
-
Health utility values of breast cancer treatments and the impact of varying quality of life assumptions on cost‐effectiveness Int. J. Cancer (IF 6.4) Pub Date : 2024-03-13 Lindy M. Kregting, Noëlle J. M. C. Vrancken Peeters, Marloes E. Clarijs, Linetta B. Koppert, Ida J. Korfage, Nicolien T. van Ravesteyn
In breast cancer research, utility assumptions are outdated and inconsistent which may affect the results of quality adjusted life year (QALY) calculations and thereby cost‐effectiveness analyses (CEAs). Four hundred sixty four female patients with breast cancer treated at Erasmus MC, the Netherlands, completed EQ‐5D‐5L questionnaires from diagnosis throughout their treatment. Average utilities were
-
Trends in management and outcomes of colon cancer in the United States over 15 years: Analysis of the National Cancer Database Int. J. Cancer (IF 6.4) Pub Date : 2024-03-08 Nir Horesh, Sameh Hany Emile, Zoe Garoufalia, Rachel Gefen, Peige Zhou, Steven D. Wexner
-
Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population‐based cancer registry study Int. J. Cancer (IF 6.4) Pub Date : 2024-03-08 Ariana Znaor, Sultan Eser, Karima Bendahhou, Wael Shelpai, Najla Al Lawati, Amani ELBasmi, Elias Mamo Alemayehu, Mohammed Adnane Tazi, Cankut Yakut, Marion Piñeros
-
Does the duration of diabetes increase the risk of cancer? A nationwide population‐based cohort of patients with new‐onset diabetes and a matched reference cohort Int. J. Cancer (IF 6.4) Pub Date : 2024-03-07 Petrus Lohi, Anssi Auvinen, Leo Niskanen, Timo Partonen, Jari Haukka
-
Diabetes and cancer: Doubts of a causal link Int. J. Cancer (IF 6.4) Pub Date : 2024-03-07 Andrew G. Renehan, Owen Tipping, Mengying Wang
A link between diabetes and cancer was noted as early as 1914,1 but received little attention until the 2000s. Excess body fatness, a key risk factor for type 2 diabetes, is associated with at least 13 obesity-related cancers, namely esophageal adenocarcinoma, gastric cardia, colorectal, liver, gallbladder, pancreatic, post-menopausal breast, endometrial, ovarian, kidney renal-cell, meningioma, thyroid
-
Targeted DNA sequencing of high‐grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression Int. J. Cancer (IF 6.4) Pub Date : 2024-03-06 Petr Holý, Viktor Hlaváč, Karolína Šeborová, Simona Šůsová, Tereza Tesařová, Lukáš Rob, Martin Hruda, Jiří Bouda, Alena Bartáková, Marcela Mrhalová, Kateřina Kopečková, Mohammad Al Obeed Allah, Jiří Špaček, Iva Sedláková, Pavel Souček, Radka Václavíková
High‐grade serous ovarian carcinoma (HGSC) is the most common subtype of ovarian cancer and is among the most fatal gynecological malignancies worldwide, due to late diagnosis at advanced stages and frequent therapy resistance. In 47 HGSC patients, we assessed somatic and germline genetic variability of a custom panel of 144 known or suspected HGSC‐related genes by high‐coverage targeted DNA sequencing
-
-
Reduced adherence to cervical cancer screening. The importance of information and education for women with low education and low‐income Int. J. Cancer (IF 6.4) Pub Date : 2024-03-06 Antonio V. Sterpetti, Raimondo Gabriele, Immacolata Iannone, Paolo Sapienza, Giuseppe D'Ermo, Luca Dimarzo, Valeria Borrelli
-
Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy Int. J. Cancer (IF 6.4) Pub Date : 2024-03-06 Michael Masetti, Salah‐Eddin Al‐Batran, Thorsten O. Goetze, Peter Thuss‐Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
-
Germline variants of DNA repair and immune genes in lymphoma from lymphoma‐cancer families Int. J. Cancer (IF 6.4) Pub Date : 2024-03-06 Xiaogan Wang, Lijuan Deng, Lingyan Ping, Yunfei Shi, Haojie Wang, Feier Feng, Xin Leng, Yahan Tang, Yan Xie, Zhitao Ying, Weiping Liu, Jun Zhu, Yuqin Song
-
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor‐positive, HER‐2‐negative advanced breast cancer: Results from the open‐label, multicentre, non‐interventional BRAWO study Int. J. Cancer (IF 6.4) Pub Date : 2024-03-06 Diana Lüftner, Florian Schuetz, Andreas Schneeweiss, Andreas Hartkopf, Wilhelm Bloch, Thomas Decker, Christoph Uleer, Oliver Stötzer, Frank Foerster, Marcus Schmidt, Christoph Mundhenke, Hans Tesch, Christian Jackisch, Thomas Fischer, Julia Kreuzeder, Gernot Guderian, Peter A. Fasching
-
Revealing genes associated with cervical cancer in distinct immune cells: A comprehensive Mendelian randomization analysis Int. J. Cancer (IF 6.4) Pub Date : 2024-03-06 Ning Li, Huan Yi, Wen Sun, Jan Sundquist, Kristina Sundquist, Xiaoyu Zhang, Deqiang Zheng, Jianguang Ji
-
Improving colon cancer screening in Poland. In search of the Holy Grail Int. J. Cancer (IF 6.4) Pub Date : 2024-03-04 Krzysztof Jeziorski
-
The impact of loss to follow‐up in the Dutch organised HPV‐based cervical cancer screening programme Int. J. Cancer (IF 6.4) Pub Date : 2024-03-04 E. M. G. Olthof, C. A. Aitken, A. G. Siebers, F. J. van Kemenade, I. M. C. M. de Kok
-
DeepCG: A cell graph model for predicting prognosis in lung adenocarcinoma Int. J. Cancer (IF 6.4) Pub Date : 2024-03-02 Baoyi Zhang, Chenyang Li, Jia Wu, Jianjun Zhang, Chao Cheng
-
Unraveling the cross‐talk between N6‐methyladenosine modification and non‐coding RNAs in breast cancer: Mechanisms and clinical implications Int. J. Cancer (IF 6.4) Pub Date : 2024-03-02 Xuan Liu, Xuelong Xie, Chentao Sui, Xuexue Liu, Miao Song, Qing Luo, Ping Zhan, Jia Feng, Jinbo Liu
-
Healthy dietary patterns and risk of prostate cancer in men at high genetic risk Int. J. Cancer (IF 6.4) Pub Date : 2024-03-02 Yiwen Zhang, Konrad H. Stopsack, Mingyang Song, Lorelei A. Mucci, Binkai Liu, Kathryn L. Penney, Fred K. Tabung, Edward Giovannucci, Anna Plym
-
Metabolomic landscape of overall and common cancers in the UK Biobank: A prospective cohort study Int. J. Cancer (IF 6.4) Pub Date : 2024-03-02 Chanchan Hu, Yi Fan, Zhifeng Lin, Xiaoxu Xie, Shaodan Huang, Zhijian Hu
Information about the NMR metabolomics landscape of overall, and common cancers is still limited. Based on a cohort of 83,290 participants from the UK Biobank, we used multivariate Cox regression to assess the associations between each of the 168 metabolites with the risks of overall cancer and 20 specific types of cancer. Then, we applied LASSO to identify important metabolites for overall cancer
-
The risk of vaginal, vulvar and anal precancer and cancer according to high‐risk HPV status in cervical cytology samples Int. J. Cancer (IF 6.4) Pub Date : 2024-02-29 Sofie Lindquist, Kirsten Frederiksen, Lone Kjeld Petersen, Susanne K. Kjær
-
Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study Int. J. Cancer (IF 6.4) Pub Date : 2024-02-27 Shaoyan Xi, Shimeng Jiang, Hainan Li, Qitao Huang, Jiabin Lu, Xing Zhang, Zhi Li, Jing Zeng
-
Comment on “Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case‐cohort study” Int. J. Cancer (IF 6.4) Pub Date : 2024-02-24 Rui Wang, Xin‐Zu Chen
-
Correction to “Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells” Int. J. Cancer (IF 6.4) Pub Date : 2024-02-19
Mandal, C., Tringali, C., Mondal, S., Anastasia, L., Chandra, S., Venerando, B. and Mandal, C. (2010), Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells. Int. J. Cancer, 126: 337–349. doi:10.1002/ijc.24733 Concerns were raised by a third party regarding the appearance of Figure 2c
-
Reproductive late effects and testosterone replacement therapy in male childhood cancer survivors: A population‐based study (the Fex‐Can study) Int. J. Cancer (IF 6.4) Pub Date : 2024-02-22 Anu Haavisto, Claudia Lampic, Lena Wettergren, Päivi M. Lähteenmäki, Kirsi Jahnukainen
Childhood cancer survivors are at risk of various endocrine late effects affecting their quality of life. The aim of this study was to assess the prevalence and predictors of endocrine and reproductive outcomes in young adult survivors. A secondary aim was to assess possible associations between testosterone replacement therapy (TRT) and other endocrine, cardiovascular and psychosocial late effects
-
Exploring causal correlations between circulating levels of cytokines and colorectal cancer risk: A Mendelian randomization analysis Int. J. Cancer (IF 6.4) Pub Date : 2024-02-22 Cong Meng, Liting Sun, Jinyao Shi, Yang Li, Jiale Gao, Yishan Liu, Pengyu Wei, Zhengyang Yang, Hongwei Yao, Zhongtao Zhang
-
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence Int. J. Cancer (IF 6.4) Pub Date : 2024-02-21 Xian‐Yang Qin, Yohei Shirakami, Masao Honda, Shiou‐Hwei Yeh, Kazushi Numata, Ya‐Yun Lai, Chiao‐Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo
The proto‐oncogene MYCN expression marked a cancer stem‐like cell population in hepatocellular carcinoma (HCC) and served as a therapeutic target of acyclic retinoid (ACR), an orally administered vitamin A derivative that has demonstrated promising efficacy and safety in reducing HCC recurrence. This study investigated the role of MYCN as a predictive biomarker for therapeutic response to ACR and prognosis
-
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer Int. J. Cancer (IF 6.4) Pub Date : 2024-02-20 Klara Hammarström, Luís Nunes, Lucy Mathot, Artur Mezheyeuski, Emma Lundin, Nafsika Korsavidou Hult, Israa Imam, Emerik Osterlund, Tobias Sjöblom, Bengt Glimelius
-
Association between reproductive factors with lung cancer incidence and mortality: A pooled analysis of over 308,000 females in the Asia cohort consortium Int. J. Cancer (IF 6.4) Pub Date : 2024-02-20 Xin Yin, Rie Kishida, Sarah Krull Abe, Md. Rashedul Islam, Md. Shafiur Rahman, Eiko Saito, Qing Lan, Batel Blechter, Melissa Merritt, Ji‐Yeob Choi, Aesun Shin, Ryoko Katagiri, Xiao‐Ou Shu, Norie Sawada, Akiko Tamakoshi, Woon‐Puay Koh, Ichiro Tsuji, Chisato Nagata, Sue K. Park, Sun‐Seog Kweon, Yu‐Tang Gao, Shoichiro Tsugane, Takashi Kimura, Jian‐Min Yuan, Yukai Lu, Seiki Kanemura, Yumi Sugawara, Keiko
-
Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing cervical HR-HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide Int. J. Cancer (IF 6.4) Pub Date : 2024-02-17 Tian-Meng Wen, Xiao-Qian Xu, Xue-Lian Zhao, Cheng-Hao Pan, Yu-Shu Feng, Ting-Ting You, Meng Gao, Shang-Ying Hu, Fang-Hui Zhao
-
Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women Int. J. Cancer (IF 6.4) Pub Date : 2024-02-15 Sabina Rinaldi, Laure Dossus, Pekka Keski-Rahkonen, Agneta Kiss, Anne-Sophie Navionis, Carine Biessy, Ruth Travis, Elisabete Weiderpass, Isabelle Romieu, Anne Kirstine Eriksen, Anne Tjonneland, Marina Kvaskoff, Marianne Canonico, Thérèse Truong, Verena Katzke, Rudolf Kaaks, Alberto Catalano, Salvatore Panico, Giovanna Masala, Rosario Tumino, Marko Lukic, Karina Standahl Olsen, Raul Zamora-Ros, Carmen
-
Neoadjuvant chemo- or chemo-radiation-therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass Int. J. Cancer (IF 6.4) Pub Date : 2024-02-14 Maren N. Stillger, Konrad Kurowski, Peter Bronsert, Eva Brombacher, Clemens Kreutz, Martin Werner, Laura Tang, Sylvia Timme-Bronsert, Oliver Schilling
-
Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs Int. J. Cancer (IF 6.4) Pub Date : 2024-02-14 Zhenbang Gu, Peng Huang, Jiali Zhao, Chen Luo, Lingmin Liao, Anwen Liu, Long Huang
-
Deposition of onco-histone H3.3-G34W leads to DNA repair deficiency and activates cGAS/STING-mediated immune responses Int. J. Cancer (IF 6.4) Pub Date : 2024-02-14 Daniela Mancarella, Henrik Ellinghaus, Gianluca Sigismondo, Olivera Veselinov, Alexander Kühn, Ashish Goyal, Mark Hartmann, Jörg Fellenberg, Jeroen Krijgsveld, Christoph Plass, Odilia Popanda, Peter Schmezer, Ali Bakr
-
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation Int. J. Cancer (IF 6.4) Pub Date : 2024-02-14 Eva Welsch, Barbara Holzer, Eva Schuster, Hannah Fabikan, Christoph Weinlinger, Elisabeth Hauptmann-Repitz, Oliver Illini, Maximilian J. Hochmair, Michael B. Fischer, Esther Weiss, Robert Zeillinger, Eva Obermayr
-
Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all-cause mortality Int. J. Cancer (IF 6.4) Pub Date : 2024-02-12 Abisola M. Oyelere, Dieuwertje E. Kok, Daniel Bos, Marc J. Gunter, Pietro Ferrari, Pekka Keski-Rahkonen, Johannes H. W. de Wilt, Henk K. van Halteren, Ewout A. Kouwenhoven, Fränzel J. B. van Duijnhoven, Ellen Kampman
-
Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9-expressing conventional type-1 dendritic cells Int. J. Cancer (IF 6.4) Pub Date : 2024-02-12 Momo Kamei, Kazuhiko Matsuo, Yusuke Yoshida, Kaho Shimada, Mayuko Otsuki, Nao Fujimoto, Miho Ishibashi, Ying-Shu Quan, Fumio Kamiyama, Yuta Hara, Shiki Takamura, Takashi Nakayama
-
Immunosuppression and cancer risk in kidney transplant recipients: A retrospective cohort study Int. J. Cancer (IF 6.4) Pub Date : 2024-02-12 Ruth Sapir-Pichhadze, Claudie Laprise, Marie-Eve Beauchamp, Mohammed Kaouache, Xun Zhang, Alexia Della Vecchia, Laurent Azoulay, Eduardo L. Franco, Michal Abrahamowicz, Belinda Nicolau
-
Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis Int. J. Cancer (IF 6.4) Pub Date : 2024-02-10 Monireh Sadat Seyyedsalehi, Paolo Boffetta
-
Environmental drivers of the rising incidence of early-onset colorectal cancer in the United States Int. J. Cancer (IF 6.4) Pub Date : 2024-02-10 Jianjiu Chen, Mary Beth Terry, Piero Dalerba, Chin Hur, Jianhua Hu, Wan Yang
-
Long-term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The ELAPSE project Int. J. Cancer (IF 6.4) Pub Date : 2024-02-10 Gabriele Nagel, Jie Chen, Andrea Jaensch, Lea Skodda, Sophia Rodopoulou, Maciej Strak, Kees de Hoogh, Zorana J. Andersen, Tom Bellander, Jørgen Brandt, Daniela Fecht, Francesco Forastiere, John Gulliver, Ole Hertel, Barbara Hoffmann, Ulla Arthur Hvidtfeldt, Klea Katsouyanni, Matthias Ketzel, Karin Leander, Patrik K. E. Magnusson, Göran Pershagen, Debora Rizzuto, Evangelia Samoli, Gianluca Severi, Massimo
-
Ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study Int. J. Cancer (IF 6.4) Pub Date : 2024-02-10 Muluken Gizaw, Donald Maxwell Parkin, Ole Stöter, Phiona Bukirwa, Edom Seife, Gladys Chesumbai, Anne Korir, Biying Liu, Shyam S. Manraj, Guy Nda, Nontuthuzelo I. M. Somdyala, Eva Johanna Kantelhardt
-
Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315) Int. J. Cancer (IF 6.4) Pub Date : 2024-02-08 Martin Sebastian, Wilfried E. E. Eberhardt, Eyck von der Heyde, Steffen Dörfel, Jörg Wiegand, Clemens Schiefer, Christoph Losem, Martina Jänicke, Annette Fleitz, Stefan Zacharias, Anja Kaiser-Osterhues, Annette Hipper, Corinna Dietel, Annalen Bleckmann, Robin Benkelmann, Michael Boesche, Christian Grah, Annette Müller, Frank Griesinger, Michael Thomas
-
Changes in mortality associated with different hematologic malignancies during the pandemic in the United States Int. J. Cancer (IF 6.4) Pub Date : 2024-02-09 Ugo Fedeli, Claudio Barbiellini Amidei, Xuesong Han, Ahmedin Jemal
-
Incidence of late recurrence and second primary cancers 5–10 years after non-metastatic colorectal cancer Int. J. Cancer (IF 6.4) Pub Date : 2024-02-07 Jesper Nors, Kåre Andersson Gotschalck, Rune Erichsen, Claus Lindbjerg Andersen
-
Age-related phenotypes in breast cancer: A population-based study Int. J. Cancer (IF 6.4) Pub Date : 2024-02-06 Amalie A. Svanøe, Rasmus O. C. Humlevik, Gøril Knutsvik, Anna K. M. Sæle, Cecilie Askeland, Lise M. Ingebriktsen, Ulrikke Hugaas, Amalie B. Kvamme, Amalie F. Tegnander, Kristi Krüger, Benedicte Davidsen, Erling A. Hoivik, Turid Aas, Ingunn M. Stefansson, Lars A. Akslen, Elisabeth Wik